In this issue:
Benefits and harms of oral anticoagulant therapy in CKD
Veverimer improves metabolic acidosis in CKD patients
High- vs standard-dose influenza vaccine in haemodialysis patients
CKD is associated with increased risk of all-cause hospitalisation
Ferric citrate coordination complex in advanced CKD
Esaxerenone for the treatment of type 2 diabetes with microalbuminuria
Socioeconomic status and risk of kidney dysfunction
Nurse-led CKD management programme in UK primary care
Please login below to download this issue (PDF)